News
This year, drug companies have been living under a cloud of uncertainty created by the Trump administration. Threats of tough ...
Monthly weight-loss shots on the horizon! Learn about new drugs like MariTide and why Black participation in clinical trials ...
Amgen has transitioned into a mature, cash-generating pharma-biotech hybrid. Click here to find out why AMGN stock is a Buy.
MariTide helped participants lose up to 20% of their body weight in a year-long trial. But it could be years before the new ...
Eli Lilly and Novo Nordisk dominate the weight-loss drug market. But pharma companies like Amgen, Viking, Zealand, Structure, ...
Amgen Inc. (NASDAQ:AMGN) ranks among the best set-it-and-forget-it stocks to buy. On June 24, Piper Sandler reaffirmed its ...
Amgen Inc. (NASDAQ:AMGN) is one of the 10 Best Value Stocks to Buy According to Billionaires. On June 23, the company ...
13d
Woman's World on MSNNew GLP-1 Called MariTide Shows 20% Weight Loss-Without a PlateauDavid Petrus IbarsIn the same way weight varies from person to person, so do the best weight loss strategies. While some ...
Maridebart cafraglutide showed promising results in weight loss, offering a monthly treatment option for obesity with ...
They also have strong dividend track records. Apple and Amgen have lagged the market over the trailing-12-month period, but ...
Having to take Ozempic or other weight loss drugs can be a real pain in the ass, with users often having to jab themselves once each week. In newly released clinical trial data, Amgen’s once-monthly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results